ER
Showing 1 - 25 of 8,314
Idiopathic Pulmonary Fibrosis Trial (nalbuphine ER, Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- nalbuphine ER
- Placebo
- (no location specified)
Jul 19, 2023
Obesity Trial (Naltrexone-Bupropion (NB) Combination, Placebo)
Not yet recruiting
- Obesity
- Naltrexone-Bupropion (NB) Combination
- Placebo
- (no location specified)
Oct 18, 2023
Assessed by 18F-FES PET/CT in MBC With ER-positive Primary Tumor
Recruiting
- Breast Cancer
-
Shanghai, Shanghai, ChinaBiyun Wang, MD
Apr 5, 2023
Healthy Trial (HC-ER + 40% Alcohol, HC-ER + 20% Alcohol, HC-ER + 0% Alcohol)
Completed
- Healthy
- HC-ER + 40% Alcohol
- +2 more
- (no location specified)
Nov 8, 2022
Hepatic Impairment Trial (20 mg HC-ER)
Completed
- Hepatic Impairment
- 20 mg HC-ER
- (no location specified)
Nov 8, 2022
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)
Recruiting
- Metastatic Breast Cancer
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 26, 2023
Peri-Implantitis Trial in Van (Er, Cr: YSGG laser-assisted non-surgical mechanical therapy, Non-surgical mechanical therapy)
Completed
- Peri-Implantitis
- Er, Cr: YSGG laser-assisted non-surgical mechanical therapy
- Non-surgical mechanical therapy
-
Van, TurkeyNazli Zeynep Alpaslan
Sep 13, 2023
Healthy Trial (HC-ER 20 mg capsule (fasted), HC-ER 20 mg capsule (fed))
Completed
- Healthy
- HC-ER 20 mg capsule (fasted)
- HC-ER 20 mg capsule (fed)
- (no location specified)
Nov 8, 2022
Relative Dose Intensity of Adjuvant Chemotherapy in Older ER+
Not yet recruiting
- Breast Cancer
- (no location specified)
Aug 21, 2023
Huntington Disease Trial in Guangzhou (ER2001 injection)
Recruiting
- Huntington Disease
- ER2001 injection
-
Guangzhou, Guangdong, ChinaFirst Affiliated Hospital of Guangzhou Medical University
Aug 29, 2023
Pigmentation, Gingiva Trial (Gingival depigmentation)
Completed
- Pigmentation
- Gingiva
- Gingival depigmentation
- (no location specified)
Oct 4, 2023
Endodontic Disease, Root Canal Infection Trial in Philadelphia (Waterlase Express™, BIOLASE®, Sodium Hypochlorite)
Not yet recruiting
- Endodontic Disease
- Root Canal Infection
- Waterlase Express™, BIOLASE®
- Sodium Hypochlorite
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania, School of Dental Medicine
Jul 17, 2023
Older Women With ER+ Breast Cancer Who Omit Surgery
Recruiting
- Breast Cancer
-
Pittsburgh, PennsylvaniaUPMC Magee Womens Hospital - Surgical Oncology
Jun 13, 2023
Resistance in ER+ Breast Cancer Patients:Translational Project
Recruiting
- Breast Cancer
-
Aviano, Pordenone, Italy
- +1 more
Nov 8, 2023
Advanced Breast Cancer Trial in Lebanon (Fulvestrant, Neratinib, Alpelisib)
Not yet recruiting
- Advanced Breast Cancer
- Fulvestrant
- +4 more
-
Lebanon, New HampshireDartmouth Hitchcock Medical Center
Jun 28, 2023
Vaginal Atrophy, Dyspareunia, Laser Trial in Istanbul (Fotona Dynamis Er:YAG Laser System, Sham)
Recruiting
- Vaginal Atrophy
- +4 more
- Fotona Dynamis Er:YAG Laser System
- Sham
-
Istanbul, Turkey
- +1 more
Aug 12, 2023
Breast Cancer, ER Positive Breast Cancer Trial in Lebanon (Letrozole 2.5mg)
Recruiting
- Breast Cancer
- ER Positive Breast Cancer
- Letrozole 2.5mg
-
Lebanon, New Hampshire
- +1 more
Dec 19, 2022
Depression, Depressive Disorder, Depressive Symptoms Trial (TNX-601 ER, Placebo)
Not yet recruiting
- Depression
- +5 more
- TNX-601 ER
- Placebo
- (no location specified)
Jan 6, 2023
Refractory Chronic Cough Trial (Nalbuphine Hydrochloride, Placebo)
Not yet recruiting
- Refractory Chronic Cough
- Nalbuphine Hydrochloride
- Placebo
- (no location specified)
Jul 18, 2023
Outreach-ER: A Dementia Care Intervention Program
Enrolling by invitation
- Dementia
- Outreach-ER
-
Saint Paul, Minnesota
- +1 more
Aug 2, 2022
Asthma in Children Trial in Rochester (Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER), Enhanced
Not yet recruiting
- Asthma in Children
- Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER)
- Enhanced Care (EC)
-
Rochester, New YorkUniversity of Rochester Medical Center
May 2, 2023
Bladder Cancer Trial in Melbourne (APL-1202 and APL-1501 (Single ascending dose), APL-1202 and APL-1501 (Multiple Ascending
Not yet recruiting
- Bladder Cancer
- APL-1202 and APL-1501 (Single ascending dose)
- APL-1202 and APL-1501 (Multiple Ascending dose)
-
Melbourne, Victoria, AustraliaNucleus Network Pty Ltd
Sep 11, 2023